850157P

16:0-18:1 PI(4)P

Avanti Polar Lipids 850157P, powder

• Synonym(e): 1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′-phosphate) (ammonium salt)
• Empirische Formel (Hill-System): C₄₃H₈₈ N₂O₁₆ P₂
• CAS-Nummer: 2260795-75-1
• Molekulargewicht: 951.11
• UNSPSC-Code: 51191904
• NACRES: NA.25

Eigenschaften

• Assay: >99% (TLC)
• Form: powder
• Verpackung: pkg of 1 × 1 mg (with stopper and crimp cap (850157P-1mg)); pkg of 1 × 500 μg (with stopper and crimp cap (850157P-500ug))
• Hersteller/Markenname: Avanti Polar Lipids 850157P
• Lipid-Typ: phospholipids
• Versandbedingung: dry ice
• Lagertemp.: −20°C
• SMILES String: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[NH4+].[NH4+]

Beschreibung

Allgemeine Beschreibung

Phosphatidylinositol 4-phosphate (PI4P) is present abundantly at the plasma membrane.

Anwendung

16:0-18:1 PI(4)P (1-palmitoyl-2-oleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′-phosphate) (ammonium salt)) has been used in liposomes for phosphatidylinositol 4-phosphate 5-kinase (PIP5K) sedimentation assays.

Biochem./physiol. Wirkung

Phosphatidylinositol 4-phosphate (PI(4)P) plays a key role in modulating mitochondrial fission. It participates in protein targeting to the domains of plasma membrane by acting as a spatial cue or signpost.

Verpackung

2 mL Amber Serum Vial with Stopper and Crimp Cap (850157P-1mg)

2 mL Amber Serum Vial with Stopper and Crimp Cap (850157P-500ug)

Sicherheitshinweise

• Lagerklassenschlüssel: 11 - Combustible Solids
• WGK: WGK 3
• Flammpunkt (°F): No data available
• Flammpunkt (°C): No data available